DE69206258T2 - Sg(beta)-1,4-galaktanase und dns-sequenz. - Google Patents

Sg(beta)-1,4-galaktanase und dns-sequenz.

Info

Publication number
DE69206258T2
DE69206258T2 DE69206258T DE69206258T DE69206258T2 DE 69206258 T2 DE69206258 T2 DE 69206258T2 DE 69206258 T DE69206258 T DE 69206258T DE 69206258 T DE69206258 T DE 69206258T DE 69206258 T2 DE69206258 T2 DE 69206258T2
Authority
DE
Germany
Prior art keywords
galactanase
beta
dna sequence
obtainable
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69206258T
Other languages
English (en)
Other versions
DE69206258D1 (de
Inventor
Kurt Doerreich
Henrik Dalboge
Jan Mikkelsen
Marcel Mischler
Flemming Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69206258(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69206258D1 publication Critical patent/DE69206258D1/de
Application granted granted Critical
Publication of DE69206258T2 publication Critical patent/DE69206258T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01089—Arabinogalactan endo-beta-1,4-galactanase (3.2.1.89)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69206258T 1991-02-06 1992-02-06 Sg(beta)-1,4-galaktanase und dns-sequenz. Expired - Fee Related DE69206258T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91610007A EP0498137A1 (de) 1991-02-06 1991-02-06 Expressionssysteme
PCT/DK1992/000037 WO1992013945A1 (en) 1991-02-06 1992-02-06 Sg(b)-1,4-galactanase and a dna sequence

Publications (2)

Publication Number Publication Date
DE69206258D1 DE69206258D1 (de) 1996-01-04
DE69206258T2 true DE69206258T2 (de) 1996-03-28

Family

ID=8208762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69206258T Expired - Fee Related DE69206258T2 (de) 1991-02-06 1992-02-06 Sg(beta)-1,4-galaktanase und dns-sequenz.

Country Status (12)

Country Link
US (1) US5474922A (de)
EP (2) EP0498137A1 (de)
JP (1) JP3240002B2 (de)
AT (1) ATE130630T1 (de)
AU (1) AU649789B2 (de)
CA (1) CA2100775A1 (de)
DE (1) DE69206258T2 (de)
DK (1) DK0571475T3 (de)
ES (1) ES2080486T3 (de)
GR (1) GR3018913T3 (de)
NZ (1) NZ241560A (de)
WO (1) WO1992013945A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1321523A3 (de) * 1993-07-23 2004-03-03 DSM IP Assets B.V. Selektionmarker-genfreie rekombinante Stämme: Verfahren zur ihrer Herstellung und die Verwendung dieser Stämme
GB9320930D0 (en) * 1993-10-12 1993-12-01 Zeneca Ltd Modified fruit
GB9403423D0 (en) * 1994-02-23 1994-04-13 Unilever Plc Novel exo-(1-4)- beta-D galactanase
WO1995034223A1 (en) * 1994-06-15 1995-12-21 Novo Nordisk A/S Extracts/cloud stability
WO1997016982A1 (en) * 1995-11-06 1997-05-15 Novo Nordisk A/S Animal feed additives
JP4267696B2 (ja) * 1996-03-01 2009-05-27 ノボザイムス アクティーゼルスカブ ガラクタナーゼ活性を有する酵素
CN1212012A (zh) * 1996-03-01 1999-03-24 诺沃挪第克公司 具有半乳聚糖酶活性的酶
US6331426B1 (en) 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
CN112961852B (zh) * 2019-12-12 2023-11-21 青岛蔚蓝生物集团有限公司 一种启动子及其在棘孢曲霉基因自克隆表达中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302336A1 (fr) * 1975-02-26 1976-09-24 Baxter Laboratories Inc Procede pour la fabrication d'un melange d'enzymes
ES518412A0 (es) * 1981-12-22 1984-01-16 Novo Industri As Un metodo para la obtencion de un producto de proteina vegetal purificada.
SE461659B (sv) * 1981-12-22 1990-03-12 Novo Industri As Foerfarande foer framstaellning av enzymet sps-as med foermaaga att soenderdela hoegmolekylaer kolhydrat
US4483874A (en) * 1982-05-06 1984-11-20 Novo Industri A/S Preparation of milk substitute
DE3529221A1 (de) * 1985-08-20 1987-02-26 I Centar Biotechnologija Verfahren zur gewinnung eines pektolytischen enzympraeparats
FR2588886B1 (fr) * 1985-10-18 1988-06-24 Comite Eco Agric Prod Chanvre Procede de traitement biochimique de plantes fibreuses liberiennes ou cellulosiques et assimilees
JPH01296995A (ja) * 1988-05-21 1989-11-30 Osaka Organic Chem Ind Ltd 糖転移反応生成物の製造法
JPH02308798A (ja) * 1989-03-24 1990-12-21 Osaka Organic Chem Ind Ltd 糖転移反応生成物の製造法
JPH02268685A (ja) * 1989-04-07 1990-11-02 Tax Adm Agency 新規遺伝子、ベクター、それを用いた形質転換体及びその利用

Also Published As

Publication number Publication date
DK0571475T3 (da) 1996-03-04
DE69206258D1 (de) 1996-01-04
CA2100775A1 (en) 1992-08-07
EP0498137A1 (de) 1992-08-12
AU1246792A (en) 1992-09-07
WO1992013945A1 (en) 1992-08-20
GR3018913T3 (en) 1996-05-31
NZ241560A (en) 1993-09-27
EP0571475B1 (de) 1995-11-22
JP3240002B2 (ja) 2001-12-17
AU649789B2 (en) 1994-06-02
ES2080486T3 (es) 1996-02-01
US5474922A (en) 1995-12-12
JPH06505154A (ja) 1994-06-16
ATE130630T1 (de) 1995-12-15
EP0571475A1 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
DK42588D0 (da) Protein med prokoagulantaktivitet af human faktor viii:c-typen, dets fremstilling og anvendelse samt cdna, som koder det
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
DK163930C (da) Biologisk aktivt peptid og peptidfragment deraf med natriuretisk, diuretisk og vasodilataterende aktivitet og terapeutisk middel indeholdende et saadant peptid eller peptidfragment
DK68088D0 (da) Cycliske dioner samt deres anvendelse som herbicider og plantevaekstregulerende midler
EP0337967A3 (en) Compositions inducing the binding between parts of living mineralized tissue
KR0180256B1 (en) Bpc peptides, their preparation and use
DK77490A (da) Substituerede arylurinstofderivater, deres fremstilling og anvendelse som soedemidler
DE69206258D1 (de) Sg(beta)-1,4-galaktanase und dns-sequenz.
DE3789530T2 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
ES2058479T3 (es) Compuestos peptidicos.
DE3667870D1 (de) Drei-pol-regler fuer glasfaser-spinndueser.
ZA862484B (en) Peptides
AR230998A1 (es) Compuestos de acido 1-amino-4-(1'-(2"-fenilamino-4-cloro-1",3",5"-triazin-6"-il)-amino-3'-amino-2',4',6'-trimetil-5'-sulfofenil)-amino-antraquinon-2-sulfonico,su preparacion,preparados que los contienen y procedimientos de tenido
DK610287D0 (da) Peptider, deres fremstilling og anvendelse
DK6087A (da) 1,6-anhydro-beta-hexopyranosederivater samt deres anvendelse som herbicider og plantevaekstregulerende midler
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
Drake et al. Effects of Elevated CO2 on Chesapeake Bay Wetlands. I. Description of the Study Site
BR8503805A (pt) Fixacao do nitrogenio,por meio de descargas eletricas de alta tensao e frequencia,aplicadas sobre agua de cal pulverizada junto com ar atmosferico ou mistura de nitrogenio e oxigenio
EP0264017A3 (en) Pharmaceutical compositions having healing activity
IT8551905V0 (it) Dispositivo per serraggio scarponida sci con possibilita' di allentamento o parziale o totale realizzato da uno stesso comando.
ATE103977T1 (de) Klonierung und expression des sauren fibroblastenwachstumsfaktors.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES A/S, BAGSVAERD, DK

8339 Ceased/non-payment of the annual fee